TrialPLoS medicine2018

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

Raphael J Landovitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.